Sign in
PETV Stock Price, Chart, Stats & News
PetVivo Holdings, Inc.
Save
PetVivo Holdings, Inc. (PETV) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
PETV chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 66.05% |
Operating margin | -735.94% |
Pretax margin | -893.26% |
Net margin | -893.26% |
Effective tax rate | – |
ROA | -226.91% |
ROE | -256.06% |
D/E | 0.02x |
Interest coverage ratio | -5.87x |
PETV valuation
P/E | – |
P/S | 17.93x |
P/B | 7.33x |
P/CF | -3.79x |
P/FCF | -2.83x |
P/OCF | -3.79x |
PEG | -1.02x |
EV multiple | -2.52x |
About
PetVivo Holdings, Inc. operates as a biomedical technology firm, specializing in the invention, commercialization, and licensing of advanced medical devices and biomaterials intended to treat a variety of ailments and diseases affecting animals. Its flagship product is Spryng, an intra-articular injection administered by veterinarians to effectively alleviate lameness and joint conditions, such as osteoarthritis, in canines and equines. The company's development pipeline further includes seventeen therapeutic devices poised for both veterinary and human clinical applications.
Similar securities
Based on sector and market capitalization
Report issue